A review on currently available potential therapeutic options for COVID-19
S Ohadian Moghadam - International Journal of General Medicine, 2020 - Taylor & Francis
A series of unexplained pneumonia cases currently were first reported in December 2019 in
Wuhan, China. Official names have been announced for the virus responsible, previously …
Wuhan, China. Official names have been announced for the virus responsible, previously …
[PDF][PDF] Medical management of COVID-19: treatment options under consideration
N Kumar, S Kumar - International Journal of Advances in Medicine, 2020 - academia.edu
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first
reported in Wuhan, China in December 2019. Despite the worsening trends of COVID-19 …
reported in Wuhan, China in December 2019. Despite the worsening trends of COVID-19 …
[HTML][HTML] Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
HI Shih, CJ Wu, YF Tu, CY Chi - Biomedical journal, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by a novel
coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in …
coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in …
[HTML][HTML] Review of pharmacotherapy trialed for management of the coronavirus disease-19
K Hall, F Mfone, M Shallcross… - The Eurasian Journal of …, 2021 - ncbi.nlm.nih.gov
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been
substantial progress in the pharmacologic treatment and supportive care of patients …
substantial progress in the pharmacologic treatment and supportive care of patients …
[HTML][HTML] COVID-19: Current developments and further opportunities in drug delivery and therapeutics
SARS-CoV-2 has affected people from all age groups, races and ethnicities. Given that
many infected individuals are asymptomatic, they transmit the disease to others …
many infected individuals are asymptomatic, they transmit the disease to others …
Possible therapeutic agents for COVID-19: a comprehensive review
KM Elhusseiny, FAE Abd-Elhay… - Expert Review of Anti …, 2020 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
[HTML][HTML] COVID-19 vaccines, effectiveness, and immune responses
HI Abufares, L Oyoun Alsoud, MAY Alqudah… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
Coronavirus disease 2019 (COVID-19): Current situation and therapeutic options
Coronavirus disease 2019 (COVID-19) is defined as an illness caused by SARS-CoV-2
(severe acute respiratory syndrome coronavirus 2). COVID-19 was first reported in the …
(severe acute respiratory syndrome coronavirus 2). COVID-19 was first reported in the …
Potential COVID‐19 therapeutic agents and vaccines: an evidence‐based review
Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2
pandemic has become a global health concern. Currently, some therapies and vaccines …
pandemic has become a global health concern. Currently, some therapies and vaccines …
[HTML][HTML] Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review
Abstract Coronavirus disease-2019 (COVID-19), associated with the outbreak of deadly
virus originating in Wuhan, China, is now a global health emergency and a matter of serious …
virus originating in Wuhan, China, is now a global health emergency and a matter of serious …